KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacific Biosciences Of California (PACB) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Pacific Biosciences Of California (PACB) over the last 17 years, with Q3 2025 value amounting to -$298.7 million.

  • Pacific Biosciences Of California's Enterprise Value rose 3661.13% to -$298.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$298.7 million, marking a year-over-year increase of 3661.13%. This contributed to the annual value of -$389.9 million for FY2024, which is 3824.5% up from last year.
  • Pacific Biosciences Of California's Enterprise Value amounted to -$298.7 million in Q3 2025, which was up 3661.13% from -$314.7 million recorded in Q2 2025.
  • In the past 5 years, Pacific Biosciences Of California's Enterprise Value registered a high of -$298.7 million during Q3 2025, and its lowest value of -$1.2 billion during Q1 2021.
  • Its 5-year average for Enterprise Value is -$731.1 million, with a median of -$772.3 million in 2022.
  • Its Enterprise Value has fluctuated over the past 5 years, first crashed by 85393.83% in 2021, then surged by 3893.91% in 2025.
  • Quarter analysis of 5 years shows Pacific Biosciences Of California's Enterprise Value stood at -$1.0 billion in 2021, then rose by 26.05% to -$772.3 million in 2022, then rose by 18.24% to -$631.4 million in 2023, then soared by 38.24% to -$389.9 million in 2024, then rose by 23.41% to -$298.7 million in 2025.
  • Its Enterprise Value was -$298.7 million in Q3 2025, compared to -$314.7 million in Q2 2025 and -$343.1 million in Q1 2025.